PATENT CLAIM ANALYSIS

Application Number: 15744211
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "093400"]

Abstract:
This invention relates to new uses of  Bifidobacteria  (particularly, although not exclusively, probiotic  Bifidobacteria ), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction, dilated cardiomyopathy, inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditisl, and congestive heart failure.

Claim (Index 8):
The method of  claim 1 , wherein the bacterium is administered for a period of at least 9 days and not exceeding 14 days.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.40426
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13384748', '14983827', '13505088', '12993900', '12447572']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7203541252785379
- 35 USC 102 Novelty (BERT): 0.5324325629666797
- Combined Prediction Score: 0.7015619690473521
- Mean Citation Score: 274.385644
- Max Citation Score: 318.3968799999999
- Similarity Product: 192.6634437231636

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test